By Karen Roman
Toronto-based biotech company Radiant Biotherapeutics announced the designation of Deborah Geraghty, Ph.D., as President and Chief Executive Officer.
The company also appointed Stefan Larson, Ph.D., as Chair of the Board of Directors, and Ingmar Bruns, M.D., Ph.D., as Board Member, it said in a statement.
Dr. Geraghty has over 20 years of financial, operational, and strategic experience leading biopharmaceutical companies and she is the former President and CEO of Anokion SA, the company said.
Dr. Larson serves on diverse biotech boards including Prilenia Therapeutics and Apnimed, while Dr. Bruns is Chief Medical Officer of Zentalis.
“Dr. Geraghty brings a proven track record of building and transforming innovative biotechnology companies and we are delighted to welcome her to Radiant,” Dr. Larson said. “Her deep industry expertise and strategic vision make her the ideal CEO to lead Radiant through this next phase of growth.”
READ MORE FROM HEALTHCARE EDGE
Ascentage Pharma Names CFO & SVP of Global Corporate Development & Finance
Register for our weekly newsletter HERE
Contact:
Exec Edge
Click HERE to follow us on LinkedIn
